Circulating tumor DNA as part of the routine work-up for patients with suspected advanced lung cancer

Liquid biopsy (LB) is a useful tool in patients with advanced non-small cell lung cancer (aNSCLC) to detect actionable molecular alterations and thereby allow genotype-matched therapies. Currently, LB is recommended for individuals diagnosed with aNSCLC who have an insufficient tissue sample or diff...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Emma Holjak, Tia Brasoveanu, Saurav Verma, Saqib Khan, Morgan Black, Inderdeep Dhaliwal, Michael Mitchell, Rahul Nayak, Mehdi Qiabi, Richard Inculet, Dalilah Fortin, Richard Malthaner, Matthew Cecchini, Anna Lapuk, Daniel Breadner
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2025-12-01
Saila:	The Journal of Liquid Biopsy
Gaiak:	Liquid biopsy NSCLC ctDNA
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2950195425001596
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!